FDA: For Niaspan Reduced Flushing Claim, Pre-Defined Criteria Necessary

Abbott would also need a “good-sized study” to support such a claim, CDER Metabolism and Endocrinology Products Deputy Director Colman tells “The Pink Sheet” DAILY.